Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids.
<h4>Introduction</h4>Despite evidence of possible patient harm and substantial costs, medication overuse is persistent. Patient reaction is one potential barrier to deprescribing, but little research has assessed this in specific instances of medication discontinuation. We sought to unde...
Guardado en:
Autores principales: | Toral J Parikh, Krysttel C Stryczek, Chris Gillespie, George G Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T Rinne, Renda Soylemez Wiener, David H Au, Christian D Helfrich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7c6335a330a4bc196aa3b67aadcaa5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial
por: Damien Cateau, et al.
Publicado: (2021) -
Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Joy Lee, et al.
Publicado: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021) -
Effect of Inhaled Corticosteroids on Blood Glucose Homeostasis in Asthmatic Children
por: Alshaimaa Essam, et al.
Publicado: (2020) -
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Ulrich Bergler, et al.
Publicado: (2021)